摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(5-嘧啶基)丁醛 | 260441-11-0

中文名称
4-(5-嘧啶基)丁醛
中文别名
——
英文名称
4-(5-pyrimidyl)butyraldehyde
英文别名
4-(Pyrimidin-5-YL)butanal;4-pyrimidin-5-ylbutanal
4-(5-嘧啶基)丁醛化学式
CAS
260441-11-0
化学式
C8H10N2O
mdl
——
分子量
150.18
InChiKey
JDMHCCLUXFMNJL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    11
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    42.8
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(3,5-dimethylphenyl)tryptamine4-(5-嘧啶基)丁醛 在 sodium cyanoborohydride 、 magnesium sulfate 作用下, 以 甲醇 为溶剂, 生成 {2-[2-(3,5-Dimethyl-phenyl)-1H-indol-3-yl]-ethyl}-(4-pyrimidin-5-yl-butyl)-amine
    参考文献:
    名称:
    Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnRH Receptor Antagonists
    摘要:
    A series of heterocyclic 2-(3,5-dimethylphenyl)tryptamine derivatives was prepared and evaluated on a rat gonadotropin releasing hormone receptor assay. The carbon tether length and heterocyclic ring attached to the amino group of 2-(3,5-dimethylphenyl)tryptamine were varied. Several of these derivatives were potent GnRH antagonists with the most potent compound having an IC50 of 16nM. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00133-0
  • 作为产物:
    描述:
    参考文献:
    名称:
    Heterocyclic Derivatives of 2-(3,5-Dimethylphenyl)tryptamine as GnRH Receptor Antagonists
    摘要:
    A series of heterocyclic 2-(3,5-dimethylphenyl)tryptamine derivatives was prepared and evaluated on a rat gonadotropin releasing hormone receptor assay. The carbon tether length and heterocyclic ring attached to the amino group of 2-(3,5-dimethylphenyl)tryptamine were varied. Several of these derivatives were potent GnRH antagonists with the most potent compound having an IC50 of 16nM. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(01)00133-0
点击查看最新优质反应信息

文献信息

  • Arylpiperazines and their use as metalloproteinase inhibiting agents (MMP)
    申请人:AstraZeneca AB
    公开号:US20040171641A1
    公开(公告)日:2004-09-02
    Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13. 1
    公式(I)的芳基哌嗪物可用作金属蛋白酶抑制剂,特别是作为MMP 13.1的抑制剂。
  • ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)
    申请人:AstraZeneca AB
    公开号:EP1109787B1
    公开(公告)日:2006-05-17
  • US6734184B1
    申请人:——
    公开号:US6734184B1
    公开(公告)日:2004-05-11
  • US7342020B2
    申请人:——
    公开号:US7342020B2
    公开(公告)日:2008-03-11
  • [EN] ARYLPIPERAZINES AND THEIR USE AS METALLOPROTEINASE INHIBITING AGENTS (MMP)<br/>[FR] ARYLPIPERAZINES ET LEUR EMPLOI COMME INHIBITEURS DES METALLOPROTEINASES
    申请人:ZENECA LTD
    公开号:WO2000012478A1
    公开(公告)日:2000-03-09
    Arylpiperazines of formula (I) useful as metalloproteinase inhibitors, especially as inhibitors of MMP 13.
查看更多